We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer.
- Authors
Draisma, Gerrit; Boer, Rob; Otto, Suzie J; van der Cruijsen, Ingrid W; Damhuis, Ronald A M; Schröder, Fritz H; de Koning, Harry J
- Abstract
Screening for prostate cancer advances the time of diagnosis (lead time) and detects cancers that would not have been diagnosed in the absence of screening (overdetection). Both consequences have considerable impact on the net benefits of screening.
- Publication
Journal of the National Cancer Institute, 2003, Vol 95, Issue 12, p868
- ISSN
1460-2105
- Publication type
Journal Article
- DOI
10.1093/jnci/95.12.868